✦ LIBER ✦

A benefit of clinical trials

✍ Scribed by P.A. Farling

Book ID: 108622193
Publisher: John Wiley and Sons
Year: 1989
Tongue: English
Weight: 110 KB
Volume: 44
Category: Article
ISSN: 0003-2409
DOI: 10.1111/j.1365-2044.1989.tb11258.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The benefits of a clinic-specific pilot

The benefits of a clinic-specific pilot test in a multicenter clinical trial

✍ Virginia J. Howard; Elizabeth Sides; Jan L. Smith; C. Robert Matherly; Carol Was 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 74 KB

48A Benefits of a centralized clinical t

48A Benefits of a centralized clinical trials data management system

✍ Martha J. Matza; Susan Rea Welch 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 62 KB

Pilocarpine-Ocuserts: A Clinical Trial o

Pilocarpine-Ocuserts: A Clinical Trial of Efficacy, Wear-Tolerance and Patient Benefit

✍ Goldberg, Ivan ;Hollows, Fred C 📂 Article 📅 1976 🏛 John Wiley and Sons 🌐 English ⚖ 353 KB

A cost-benefit analysis: Certification o

A cost-benefit analysis: Certification of multiple visual acuity examiners per center in multicenter clinical trials

✍ Lee McCaffrey; Jean A. Keller 📂 Article 📅 1991 🏛 Elsevier Science 🌐 English ⚖ 86 KB

Patient Expectations of Benefit from Pha

Patient Expectations of Benefit from Phase I Clinical Trials: Linguistic Considerations in Diagnosing a Therapeutic Misconception

✍ K.P. Weinfurt; Daniel P. Sulmasy; Kevin A. Schulman; Neal J. Meropol 📂 Article 📅 2003 🏛 Springer Netherlands 🌐 English ⚖ 88 KB

The correlation between patient characte

The correlation between patient characteristics and expectations of benefit from Phase I clinical trials

✍ Kevin P. Weinfurt; Liana D. Castel; Yun Li; Daniel P. Sulmasy; Andrew M. Balshem 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 105 KB

## Abstract ## BACKGROUND Patients in Phase I clinical trials sometimes report high expectations regarding the benefit of treatment. The authors examined a range of patient characteristics to determine which factors were associated with greater expectations of benefit from Phase I trials. ## METH